Page last updated: 2024-10-30

pyrrolidine-2,4-dicarboxylic acid and Temporomandibular Joint Disorders

pyrrolidine-2,4-dicarboxylic acid has been researched along with Temporomandibular Joint Disorders in 1 studies

pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor

Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bereiter, DA1
Benetti, AP1

Other Studies

1 other study available for pyrrolidine-2,4-dicarboxylic acid and Temporomandibular Joint Disorders

ArticleYear
Amino acid release at the spinomedullary junction after inflammation of the TMJ region in male and female rats.
    Pain, 2006, Dec-15, Volume: 126, Issue:1-3

    Topics: Amino Acid Transport System X-AG; Amino Acids; Animals; Arthritis; Carrier Proteins; Dicarboxylic Ac

2006